Clinical Trial Update: Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on QAX576 for eosinophilic esophagitis reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• QAX576

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED